Agreed it is huge, id love to see a study of Endometriosis - 1 in 10 women with an inflamation response & maybe it might help with the cause of that inflamation too.
Then there is ME/CFS , a complex chronic illness that has low grade inflamation in the spine and brain as a marker, and so many other topsy turvy issues......could stem cells right the multisystem disfunction that disables sufferers for decades.
However sadly we are still waiting for the pass mark. I dont share the views of those who want to blame the FDA or reference ODAC. We are ,where we are.
We know what the company has to do to provide the evidence, i really hope we are successful, for all those who know what its like to live with chronic illness and those who know them.
Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-47
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |